CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P14
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-1.56-72.8%
2024-0.90+56.1%
2023-2.06+71.3%
2022-7.17-110.8%
202166.21+147.6%
202026.74-16.3%
201931.93+285.1%
20188.29-34.9%
201712.74-28.1%
201617.73-